PCI is not better than medical therapy for stable angina? Seeing is not believing

Cleveland Clinic Journal of Medicine

Volumn 74, Issue 9, 2007, Pages 637-642

  Kereiakes, Dean J ^a,b,c,d  

^a Christ Hospital Heart and Vascular Center Lindner Research Center   (United States)

^b Ohio Heart and Vascular Center   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d The Carl & Edyth Lindner Center for Research & Education   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT CHEMOTHERAPY; ANGINA PECTORIS; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY BYPASS GRAFT; DRUG DELIVERY SYSTEM; EPIDEMIOLOGY; HEART INFARCTION; HUMAN; MORTALITY; NOTE; PROGNOSIS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; STENT; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

ANGINA PECTORIS; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CHEMOTHERAPY, ADJUVANT; CORONARY ARTERIOSCLEROSIS; CORONARY ARTERY BYPASS; DRUG DELIVERY SYSTEMS; HUMANS; MYOCARDIAL INFARCTION; PROGNOSIS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS; SELECTION BIAS; STENTS; TREATMENT OUTCOME;

EID: 34948816601     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.74.9.637     Document Type: Article

References (29)

1. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 2003; 361:13-20.
2. Mehta SR, Cannon CP, Fox KAA, et al. Routine vs. selective invasive strategies in patients with acute coronary syndromes - a collaborative meta-analysis of randomized trials. JAMA 2005; 293:2908-2917.
3. Bavry AA, Kumbhani DJ, Rassi AN, et al. Benefit of early invasive therapy in acute coronary syndromes - a meta-analysis of contemporary randomized clinical trials. J Am Coll Cardiol 2006, 48:1319-1325.
4. Henderson RA, Pocock SJ, Clayton TC, et al. Seven-year outcome in the RITA-2 trial: coronary angioplasty versus medical therapy. J Am Coll Cardiol 2003, 42:1161-1170.
5. Parisi AF, Folland ED, Hartigan P, on behalf of the Veterans Affairs ACME Investigators. A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. Veterans Affairs ACME Investigators. N Engl J Med 1992; 326:10-16.
6. Hueb WA, Bellotti G, deOliveira SA, et al. The Medicine, Angioplasty or Surgery Study (MASS): a prospective, randomized trial of medical therapy, balloon angioplasty or bypass surgery for single proximal left anterior descending artery stenoses. J Am Coll Cardiol 1995; 26:1600-1605.
7. Pitt B, Waters D, Brown WV, et al. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. N Engl J Med 1999; 341:70-76.
8. Hueb W, Lopes NH, Gersh BJ, et al. Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II) - a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease. Circulation 2007; 115:1082-1089.
9. Steinberg BA, Steg PG, Bhatt DL, Fonarow GC, Zeymer U, Cannon CP, and the REACH Registry Investigators. Am J Cardiol 2007; 99:1212-1215.
10. Babapulle MN, Joseph L, Belisel P, et al. A hierarchial Bayesian meta-analysis of randomized clinical trials of drug-eluting stents. Lancet 2004; 363:583-591.
11. Mauri L, Hsieh W, Massaro JM, et al. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med 2007, 356:1020-1029.
12. Katritsis DG, Ioannidis JPA. Percutaneous coronary intervention versus conservative therapy in nonacute coronary artery disease - a meta-analysis. Circulation 2005; 111:2906-2912.
13. Hoffman SN, TenBrook JA, Wolf MP, et al. A meta-analysis of randomized controlled trials comparing coronary artery bypass graft with percutaneous transluminal coronary angioplasty: one- to eight-year outcomes. J Am Coll Cardiol 2003; 41:1293-1304.
14. Mercado N, Wijns W, Serruys PW, et al. One-year out-comes of coronary artery bypass graft surgery versus percutaneous coronary intervention with multiple stenting for multisystem disease: a meta-analysis of individual patient data from randomized clinical trials. J Thorac Cardiovasc Surg 2005; 130:512-519.
15. Pocock SJ, Henderson RA, Rickards AF, et al. Meta-analysis of randomized trials comparing coronary angioplasty with bypass surgery. Lancet 1995; 346:1184-1189.
16. Boden WE, O'Rourke RA, Teo KK, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 2007; 35:1503-1516.
17. Stone GW, Mehran R, Dangas G, Lansky AJ, Kornowski R, Leon MB. Differential impact on survival of electrocardiographic Q-wave versus enzymatic myocardial infarction after percutaneous intervention: a device-specific analysis of 7147 patients. Circulation 2001; 104:642-647.
18. Hirsh A, Windhausen F, Tijssen JG, Verheugt FW, Cornel JH, de Winter RJ, Invasive versus Conservative Treatment in Unstable Coronary Syndrome (ICTUS) investigators. Long-term outcome after an early invasive versus selective invasive treatment strategy in patients with non-ST-elevation acute coronary syndrome and elevated cardiac troponin T (the ICTUS trial): a follow-up study. Lancet 2007; 369:827-835.
19. Hannan EL, Racz M, Holmes DR, et al. Impact of completeness of percutaneous coronary irytervention revascularization on long-term outcomes in the stent era. Circulation 2006; 113:2406-2412.
20. van den Brand MJ, Rensing BJ, Morel MA, et al. The effect of completeness of revascularization on event-free survival at one year in the ARTS trial. J Am Coll Cardiol 2002, 39:559-564.
21. Bourassa MG, Kip KE, Jacobs AK, et al. Is a strategy of intended incomplete percutaneous transluminal coronary angioplasty revascularization acceptable in nondiabetic patients who are candidates for coronary artery bypass graft surgery? The Bypass Angioplasty Revascularization Investigation (BARI). J Am Coll Cardiol 1999; 33:1627-1636.
22. Nikolsky E, Gruberg L, Patil CV, et al. Percutaneous coronary interventions in diabetic patients: is complete revascularization important? J Invas Cardiol 2004; 16:102-106.
23. Hill RA, Dundar Y, Bakhai A, et al. Drug-eluting stents: an early systematic review to inform policy. Eur Heart J 2004; 25:902-919.
24. Serruys PW, Kutryk MJ, Ong AT. Coronary-artery stents. N Engl J Med 2006, 354:483-495.
25. Boden WE, O'Rourke PA, Crawford MH, et al. Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. Veterans Affairs Non-Q-Wave Infarction Strategies in Hospital (VANQWISH) Trial Investigators. N Engl J Med 1998; 338:1785-1792.
26. Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction - summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol 2002; 40:1366-1374.
27. Mehta RH, Roe MT, Chen AY, et al. Changing practice for non-ST-segment elevation acute coronary syndromes: trends from the CRUSADE Quality improvement initiative [abstract]. Circulation 2005; 112:11-793.
28. Kramer JM, Fetteroff D, Charde FP, et al. National evaluation of long-term adherence to beta-blocker therapy after acute myocardial infarction in patients with commercial health insurance [abstract]. J Am Coll Cardiol 2004; 43:415A.
29. Steinberg BA, Steg PG, Bhatt DL, Fonarow GC, Zeymer U, Cannon CP, and the REACH Registry Investigators. Comparisons of guideline-recommended therapies in patients with documented coronary artery disease having percutaneous coronary intervention versus coronary artery bypass grafting versus medical therapy only (from the REACH International Registry). Am J Cardiol 2007; 99:1212-1215.